3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
9
Lymphoma
9
Lymphoma, Follicular
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
3
Lymphoma, Non-Hodgkin
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia
2
Immunoblastic Lymphadenopathy
2
Dendritic Cell Sarcoma, Interdigitating
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Sezary Syndrome
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Mycosis Fungoides
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Primary Effusion
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Fibrolamellar hepatocellular carcinoma
1
Interventions
niraparib
1
Prednisone
1
Docetaxel
1
Androgen Antagonists
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
Prednisone
×
Clear all
NCT06392841
2026-04-08
HARMONY
Hoosier Cancer Research Network
Phase 2
Withdrawn